Remdesivir-ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2.
Int J Antimicrob Agents
; 59(3): 106542, 2022 Mar.
Article
in En
| MEDLINE
| ID: mdl-35093538
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19 Drug Treatment
Limits:
Humans
Language:
En
Journal:
Int J Antimicrob Agents
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: